EE374 Cost-Effectiveness Analysis of Dostarlimab Plus Chemotherapy As First-Line Treatment for Metastatic Non-Squamous Non-Small Cell Lung Cancer in Japan
Abstract
Authors
Kureha Kawai Kensuke Moriwaki Kosuke MORIMOTO Munenobu Kashiwa Kojiro Shimozuma